eviCore Lab Management Revenue and Competitors
Estimated Revenue & Valuation
- eviCore Lab Management's estimated annual revenue is currently $10.2M per year.
- eviCore Lab Management's estimated revenue per employee is $216,000
Employee Data
- eviCore Lab Management has 47 Employees.
- eviCore Lab Management grew their employee count by 4% last year.
eviCore Lab Management's People
Name | Title | Email/Phone |
---|
eviCore Lab Management Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $18.2M | 75 | 0% | N/A | N/A |
#2 | $22.1M | 82 | 0% | N/A | N/A |
#3 | $137.4M | 407 | 9% | N/A | N/A |
#4 | $4.7M | 25 | -17% | N/A | N/A |
#5 | $1.6M | 10 | -76% | N/A | N/A |
#6 | $4.2M | 22 | 5% | N/A | N/A |
#7 | $7.1M | 33 | 6% | N/A | N/A |
#8 | $108.7M | 322 | 10% | N/A | N/A |
#9 | $5.5M | 29 | 4% | N/A | N/A |
#10 | $15.6M | 64 | 2% | N/A | N/A |
What Is eviCore Lab Management?
DNA Direct was founded in 2005 to address the growing need for genetic expertise and guidance across the healthcare continuum. Genetic technology is rapidly advancing and new associations between common genes and disease are being discovered every day. With more than 2000 molecular diagnostic and genetic tests available today, the impact of genetics has never been greater and is becoming an integral part of medicine and patient care. In December 2012, DNA Direct was acquired by CareCore National. We are offering patients, providers, payors and employers the most comprehensive suite of precision health services in genomic medicine. Ranging from genetic benefit management to clinical decision support, our solutions enhance clinical outcomes, improve safety and lower costs.
keywords:N/AN/A
Total Funding
47
Number of Employees
$10.2M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $9.4M | 48 | 12% | N/A |
#2 | $10.4M | 48 | 7% | N/A |
#3 | $11.4M | 49 | 4% | N/A |
#4 | $11.4M | 49 | 0% | N/A |
#5 | $11.6M | 50 | 32% | N/A |